High-Performance Liquid Chromatography (HPLC) Market Size (2024 - 2029)

High-Performance Liquid Chromatography (HPLC) Market Analysis

The High-Performance Liquid Chromatography Market size is estimated at USD 5 billion in 2024, and is expected to reach USD 6.20 billion by 2029, growing at a CAGR of 4.45% during the forecast period (2024-2029).

Factors such as advancements in HPLC technologies and the surge in usage of HPLC in pharmaceutical and bio-pharmaceutical companies are expected to drive the market's growth during the forecast period. For instance, according to the study published in the Global Journal of Medical Pharmaceutical and Biomedical Update in September 2023, high-performance liquid chromatography (HPLC) analyzes unknown compounds, providing faster resolution times, superior peak shapes, consistent responses, and enhanced precision. The benefits associated with HPLC in identifying new compounds are anticipated to increase its adoption for research applications, bolstering the market growth.

Also, according to the study published in Pharmacological Reports in March 2023, the high-performance liquid chromatography with fluorescence detection (HPLC-FLD) method presents benefits such as reduced analysis costs and increased equipment availability compared to liquid chromatography-mass spectrometry (LC-MS). Therefore, the advantages of HPLC over other analytical techniques, such as low cost and increased availability of equipment, are anticipated to increase its adoption, thereby propelling the market growth.

Moreover, several key market players have also been interested in developing and manufacturing innovative HPLC-based systems for various laboratory functions, including diagnostics. For instance, in February 2022, Shimadzu Corporation launched the Nexera XS inert high-performance liquid chromatograph globally. The Nexera XS inert incorporates rust-resistant materials and nonmetallic materials that limit the adsorption of molecules to provide stable measurements of biopharmaceuticals and medium molecule pharmaceuticals. Such launches are expected to propel market growth during the forecast period.

Therefore, advancements in HPLC technologies, the benefits of HPLC over other analytical techniques in identifying new compounds, and the surge in HPLC usage in pharmaceutical and biopharmaceutical companies are expected to drive the market's growth. However, the lack of skilled personnel and the high cost of HPLC systems will likely hinder the market's growth during the forecast period.

High-Performance Liquid Chromatography Industry Segmentation

As per the report's scope, high-performance liquid chromatography (HPLC) is used to separate, identify, and quantify the components in a given mixture. HPLC is one type of column chromatography in which the components are separated using solubility.

The high-performance liquid chromatography (HPLC) market is segmented by product type, application, end user, and geography. By product type, the market is segmented into instruments, consumables, and accessories. By instruments, the market is segmented into systems, detectors, pumps, and other instruments. By application, the market is segmented into protein expression, cloning, and other applications. By end user, the market is segmented into pharma biopharmaceutical companies, contract research organizations, and academic institutions. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.